ESPR
Esperion Therapeutics Inc
Price:  
2.80 
USD
Volume:  
4,133,964.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR EV/EBITDA

-76.7%
Upside

As of 2024-12-04, the EV/EBITDA ratio of Esperion Therapeutics Inc (ESPR) is 39.20. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ESPR's latest enterprise value is 669.92 mil USD. ESPR's TTM EBITDA according to its financial statements is 17.09 mil USD. Dividing these 2 quantities gives us the above ESPR EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.2x - 16.4x 12.0x
Forward P/E multiples 11.6x - 24.1x 16.8x
Fair Price 0.28 - 1.49 0.65
Upside -89.8% - -46.8% -76.7%
2.80 USD
Stock Price
0.65 USD
Fair Price

ESPR EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-11-21 35.39
2024-11-20 34.70
2024-11-19 34.70
2024-11-18 31.71
2024-11-15 31.36
2024-11-14 31.13
2024-11-13 32.63
2024-11-12 34.93
2024-11-11 35.97
2024-11-08 33.20
2024-11-07 31.24
2024-11-06 32.40
2024-11-05 31.36
2024-11-04 29.98
2024-11-01 30.32
2024-10-31 30.44
2024-10-30 31.47
2024-10-29 30.90
2024-10-28 31.47
2024-10-25 31.13
2024-10-24 30.67
2024-10-23 30.55
2024-10-22 31.47
2024-10-21 30.67
2024-10-18 30.44
2024-10-17 31.24
2024-10-16 31.36
2024-10-15 31.47
2024-10-14 31.01
2024-10-11 29.63
2024-10-10 28.71
2024-10-09 29.17
2024-10-08 30.78
2024-10-07 30.44
2024-10-04 31.82
2024-10-03 29.51
2024-10-02 27.90
2024-10-01 25.48
2024-09-30 25.94
2024-09-27 26.29
2024-09-26 25.83
2024-09-25 25.48
2024-09-24 25.94
2024-09-23 25.71
2024-09-20 26.29
2024-09-19 27.09
2024-09-18 26.98
2024-09-17 27.44
2024-09-16 27.21
2024-09-13 28.94